Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

358 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Completed

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

NCT06664801

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Pulmonary Associates, PA ( Site 1903) Phoenix, Arizona, United States
  • University of Colorado Anschutz Medical Campus-University of Colorado Hospital Cardiac and Vascular ( Site 1930) Aurora, Colorado, United States
  • Indiana University Health Methodist Hospital ( Site 1905) Indianapolis, Indiana, United States
  • University of Kansas Medical Center ( Site 1928) Kansas City, Kansas, United States
View all 98 locations
View Trial Details
Completed

Selexipag (ACT-293987) in Pulmonary Arterial Hypertension

NCT01106014

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • The University of Arizona, Clinical and Translational Science (CATS) Research Center Tucson, Arizona, United States
  • University of California San Diego Medical Center (La Jolla) La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 182 locations
View Trial Details
Completed

Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)

NCT00993408

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Medizinische Universitat Wien, Universitatsklinik fur Innere Medizin II, Kardiologie Vienna, Austria
  • Gasthuisberg University Hospital, Pneumology Leuven, Belgium
  • Hopital Antoine Beclere, Pneumologie Paris, France
  • Department of Respiratory Medicine, Hannover Medical School Hanover, Germany
View Trial Details

Related conditions